Skip to content

LEXARIA BIOSCIENCE CORP.: 10-Q filed 2025-07-14

What LEXARIA BIOSCIENCE CORP. reported in its quarterly report filed 2025-07-14 (fiscal Q3 2025): 39 published measures, 113 facts as tagged in accession 0001640334-25-001195.

This filing

Form
10-Q (quarterly report)
Filed
2025-07-14
Fiscal period
fiscal Q3 2025
Accession
0001640334-25-001195 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LEXARIA BIOSCIENCE CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-05-316,741,366USD
At 2024-08-318,867,789USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-05-311,574,845USD
At 2024-08-311,208,738USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-05-315,552,073USD
At 2024-08-318,036,400USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-05-314,600,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-03-01 to 2025-05-31-3,789,092USD92
2024-09-01 to 2025-05-31-9,206,003USD273
2024-12-01 to 2025-02-28-2,713,212USD90
2024-09-01 to 2024-11-30-2,703,699USD91
2024-03-01 to 2024-05-31-1,781,693USD92
2023-09-01 to 2024-05-31-3,610,555USD274
2023-12-01 to 2024-02-29-649,539USD91
2023-09-01 to 2023-11-30-1,179,323USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-09-01 to 2025-05-31-7,807,889USD273
2023-09-01 to 2024-05-31-3,067,344USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-09-01 to 2025-05-3124,645USD273
2023-09-01 to 2024-05-310USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-03-01 to 2025-05-31174,000USD92
2024-09-01 to 2025-05-31531,923USD273
2024-03-01 to 2024-05-3184,000USD92
2023-09-01 to 2024-05-31380,278USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-09-01 to 2025-05-316,046,163USD273
2023-09-01 to 2024-05-3110,315,207USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-09-01 to 2025-05-31-85,141USD273
2023-09-01 to 2024-05-31-119,018USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-05-31-60,764,775USD
At 2024-08-31-51,558,772USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-03-01 to 2025-05-3118,298,309shares92
2024-09-01 to 2025-05-3117,472,844shares273
2024-03-01 to 2024-05-3113,855,202shares92
2023-09-01 to 2024-05-3111,274,845shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-03-01 to 2025-05-31-0.21USD/shares92
2024-09-01 to 2025-05-31-0.53USD/shares273
2024-03-01 to 2024-05-31-0.13USD/shares92
2023-09-01 to 2024-05-31-0.32USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-05-31240,139USD
At 2024-08-31254,709USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-09-01 to 2025-05-31736,770USD273
2023-09-01 to 2024-05-31395,726USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-03-01 to 2025-05-31-3,750,421USD92
2024-09-01 to 2025-05-31-9,192,140USD273
2024-03-01 to 2024-05-31-1,742,919USD92
2023-09-01 to 2024-05-31-3,550,066USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-05-315,806,778USD
At 2024-08-317,897,986USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-05-311,488,131USD
At 2024-08-311,099,419USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-05-31516,420USD
At 2024-08-31516,676USD
At 2023-08-31462,625USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-05-31358,129USD
At 2024-08-31154,477USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-03-01 to 2025-05-313,924,421USD92
2024-09-01 to 2025-05-319,721,343USD273
2024-03-01 to 2024-05-311,826,919USD92
2023-09-01 to 2024-05-313,925,522USD274

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-03-01 to 2025-05-31174,000USD92
2024-09-01 to 2025-05-31529,203USD273
2024-03-01 to 2024-05-3184,000USD92
2023-09-01 to 2024-05-31375,456USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-03-01 to 2025-05-312,717,501USD92
2024-09-01 to 2025-05-316,356,637USD273
2024-03-01 to 2024-05-31573,089USD92
2023-09-01 to 2024-05-311,393,359USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-05-3119,459,179shares
At 2024-08-3115,810,205shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-05-314,591,761USD
At 2024-08-316,499,885USD
At 2024-05-318,459,081USD
At 2023-08-311,352,102USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-05-3166,378,362USD
At 2024-08-3159,599,178USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-05-31-81,073USD
At 2024-08-31-19,816USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-05-315,166,521USD
At 2025-02-286,760,768USD
At 2024-11-309,394,056USD
At 2024-08-317,659,051USD
At 2024-05-319,747,062USD
At 2024-02-296,147,840USD
At 2023-11-303,372,734USD
At 2023-08-312,680,078USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-05-31156,748USD
At 2024-08-31167,446USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-05-31116,586USD
At 2024-08-31137,366USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-05-31823,348USD
At 2024-08-311,187,817USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-03-01 to 2025-05-31-3,790,606USD92
2024-09-01 to 2025-05-31-9,214,206USD273
2024-03-01 to 2024-05-31-1,784,312USD92
2023-09-01 to 2024-05-31-3,622,083USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-03-01 to 2025-05-31-3,751,919USD92
2024-09-01 to 2025-05-31-9,267,260USD273
2024-03-01 to 2024-05-31-1,782,933USD92
2023-09-01 to 2024-05-31-3,632,421USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-03-01 to 2025-05-311,206,920USD92
2024-09-01 to 2025-05-313,364,706USD273
2024-03-01 to 2024-05-311,253,830USD92
2023-09-01 to 2024-05-312,532,163USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2024-09-01 to 2025-05-3139,215USD273
2023-09-01 to 2024-08-3142,448USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2024-09-01 to 2025-05-3127,212USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-03-01 to 2025-05-31-40,185USD92
2024-09-01 to 2025-05-31-22,066USD273
2024-03-01 to 2024-05-31-41,393USD92
2023-09-01 to 2024-05-31-72,017USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-09-01 to 2025-05-316,046,163USD273
2023-09-01 to 2024-05-314,208,731USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-09-01 to 2025-05-31203,652USD273
2023-09-01 to 2024-05-3181,759USD274

Inspect the source

Entity
LEXARIA BIOSCIENCE CORP. / CIK 0001348362
Captured
2026-09-20T07:55:03.045Z
SEC response SHA-256
c8696dbfbdb8ee1a7522ea5b45a8c2d45cb12720b3d84857c1cda6bba2861389

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001348362.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))